Thermo Fisher Scientific Thermo Fisher Scientific

Today, thermofisher announced a definitive agreement for the #acquisition of The Binding Site Group. The purchase

01 Nov 2022

Thermo Fisher Scientific to Acquire The Binding Site Group

Thermo Fisher Scientific Inc. (NYSE: TMO) (Thermo Fisher), the world leader in serving science, today announced that it has entered into a definitive agreement to acquire The Binding Site Group (The Binding Site).

31 Oct 2022

Michel Lagarde Sells 17,150 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) Stock

Several hedge funds and other institutional investors have recently bought and sold shares of TMO. Midwest Wealth Management Inc. increased its stake in Thermo Fisher Scientific by 3.1% during the 1st quarter. Midwest Wealth Management Inc. now owns 4,470 ...

26 May 2022

Thermo Fisher Scientific set for $40M expansion to Millersburg plant

The expansion will ensure a “flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19,

21 Feb 2022

Thermo Fisher Scientific set for $40M expansion to Millersburg plant

Thermo Fisher Scientific is investing $40 million to expand its manufacturing facility in Millersburg. The expansion will ensure a “flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and ...

20 Feb 2022

Thermo Fisher Scientific completes acquisition of Wilmington-based PPD

PPD’s acquisition by Thermo Fisher Scientific is finally complete. According to the company’s website, the sale was for $17.4 billion. Thermo Fisher expects the transaction to contribute $1.50 to its adjusted earnings per share next year.

09 Dec 2021

Construction underway on Thermo Fisher expansion in Chelmsford

Chelmsford's biotech corridor is expanding again with the addition of a new Thermo Fisher manufacturing facility, set to be up and running early next year.

17 May 2021

Behind Thermo Fisher™s deal to acquire PPD for $17.4B

In answering questions from analysts about the $17.4 billion deal to acquire life science firm PPD, the President and CEO of Thermo Fisher Scientific noted that the PPD team will remain intact as the

16 Apr 2021

Thermo Fisher completes $450M acquisition of San Diego COVID test maker Mesa Biotech

Mesa Biotech, a privately held San Diego company that developed one of the first rapid COVID-19 diagnostic tests to get regulatory approval, has been acquired by life sciences giant Thermo Fisher Scientific for $450 million in cash.

27 Feb 2021

@thermofisher expands portfolio by acquiring COVID-19 diagnostic company #COVID19 #Diagnostic

20 Jan 2021

Thermo Fisher Scientific to pay $550M to acquire Mesa Biotech

Thermo Fisher Scientific plans to acquire point-of-care molecular diagnostics firm Mesa Biotech for up to $550 million, the company said on Tuesday. Under the terms of a definitive agreement, Thermo Fisher will pay approximately $450 million in cash and up to an additional $100 million in cash if certain milestones are met after the acquisition.

20 Jan 2021